StonvexLoading…
StonvexStonvexStonvexCore line items from UCTT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-27 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $2.10B | $1.73B | $2.37B | $2.10B |
Operating Income | $91.20M | $35.20M | $120.40M | $185.70M |
Net Income | $23.70M | $-31.10M | $40.40M | $119.50M |
EPS (Diluted) | $0.52 | $-0.70 | $0.88 | $2.69 |
Total Assets | $1.92B | $1.87B | $1.96B | $1.87B |
Total Liabilities | $984.10M | $970.50M | $1.02B | $1.13B |
Cash & Equivalents | $313.90M | $307.00M | $358.80M | $466.50M |
Free Cash Flow OCF − CapEx | $1.50M | $60.10M | $-52.90M | $152.30M |
Shares Outstanding | 45.10M | 44.60M | 45.20M | 44.90M |